These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15502034)

  • 1. A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers.
    Rudy AC; Coda BA; Archer SM; Wermeling DP
    Anesth Analg; 2004 Nov; 99(5):1379-1386. PubMed ID: 15502034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
    Coda BA; Rudy AC; Archer SM; Wermeling DP
    Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
    Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist.
    Toyama K; Uchida N; Ishizuka H; Sambe T; Kobayashi S
    J Clin Pharmacol; 2015 Sep; 55(9):975-84. PubMed ID: 25807927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose proportionality and pharmacokinetics of extended-release (OROS®) hydromorphone: a phase 1, open-label, randomized, crossover study in healthy Taiwanese subjects.
    Vandenbossche J; Richards HM; Lu CC; Richarz U
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):217-26. PubMed ID: 24472398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users.
    Guenther S; Mickle TC; Barrett AC; Smith A; Braeckman R; Kelsh D; Vince B
    Pain Med; 2020 Mar; 21(3):511-520. PubMed ID: 30986302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules.
    Vashi V; Harris S; El-Tahtawy A; Wu D; Cipriano A
    J Clin Pharmacol; 2005 May; 45(5):547-54. PubMed ID: 15831778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
    Wermeling DP; Record KA; Kelly TH; Archer SM; Clinch T; Rudy AC
    Anesth Analg; 2006 Aug; 103(2):344-9, table of contents. PubMed ID: 16861415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
    Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
    Davis GA; Rudy AC; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.
    Wermeling DP; Clinch T; Rudy AC; Dreitlein D; Suner S; Lacouture PG
    J Pain; 2010 Jan; 11(1):24-31. PubMed ID: 19592310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydromorphone transfer into breast milk after intranasal administration.
    Edwards JE; Rudy AC; Wermeling DP; Desai N; McNamara PJ
    Pharmacotherapy; 2003 Feb; 23(2):153-8. PubMed ID: 12587803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR).
    Durnin C; Hind ID; Ghani SP; Yates DB; Cross M
    Proc West Pharmacol Soc; 2001; 44():73-4. PubMed ID: 11794000
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the thermal antinociceptive effects and pharmacokinetics of hydromorphone hydrochloride after intramuscular administration to cockatiels (Nymphicus hollandicus).
    Houck EL; Guzman DS; Beaufrère H; Knych HK; Paul-Murphy JR
    Am J Vet Res; 2018 Aug; 79(8):820-827. PubMed ID: 30058846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():3. PubMed ID: 17270058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):512-6. PubMed ID: 25255074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure.
    Puhto T; Kokki M; Hakomäki H; Spalding M; Gunnar T; Alahuhta S; Vakkala M
    Eur J Clin Pharmacol; 2020 Jul; 76(7):969-977. PubMed ID: 32363420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.